Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate ...

Neanderthal babies have always been hard to study, mostly because their remains are so rare. That scarcity has left one of ...

– Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint – 95% of patients completed five years of treatment ...

Development is moving to phase 2 LEGION-100-2a (NCT06533644) across global sites, with planned neoadjuvant prostate studies and expansion concepts in multiple solid tumors. Metastatic ...

There was nothing in the world I wanted more than to be a mom, but that first year of motherhood was anything but what I imagined.

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

The Palestinian activist was locked up in an ICE prison for a year. Now she is rebuilding her life, piece by piece and meal ...

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begins Priority Review of the NDA with a Sept. 26, 2026, decision date.

The worry never goes away, but these strategies can help make it more manageable.

Children are training harder in sports and competing more than ever, but doctors told CNA TODAY that the rising number of sports injuries is a reminder that young bodies need time to recover.